Nasopharyngeal Carcinoma: An Evolving Role for the Epstein–Barr Virus
- 1 October 2015
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 390, 339-363
- https://doi.org/10.1007/978-3-319-22822-8_14
Abstract
The Epstein–Barr herpesvirus (EBV) is an important human pathogen that is closely linked to several major malignancies including the major epithelial tumor, undifferentiated nasopharyngeal carcinoma (NPC). This important tumor occurs with elevated incidence in specific areas, particularly in southern China but also in Mediterranean Africa and some regions of the Middle East. Regardless of tumor prevalence, undifferentiated NPC is consistently associated with EBV. The consistent detection of EBV in all cases of NPC, the maintenance of the viral genome in every cell, and the continued expression of viral gene products suggest that EBV is a necessary factor for the malignant growth in vivo. However, the molecular characterization of the infection and identification of critical events have been hampered by the difficulty in developing in vitro models of NPC. Epithelial cell infection is difficult in vitro and in contrast to B-cell infection does not result in immortalization and transformation. Cell lines established from NPC usually do not retain the genome, and the successful establishment of tumor xenografts is difficult. However, critical genetic changes that contribute to the onset and progression of NPC and key molecular properties of the viral genes expressed in NPC have been identified. In some cases, viral expression becomes increasingly restricted during tumor progression and tumor cells may express only the viral nuclear antigen EBNA1 and viral noncoding RNAs. As NPC develops in the immunocompetent, the continued progression of deregulated growth likely reflects the combination of expression of viral oncogenes in some cells and viral noncoding RNAs that likely function synergistically with changes in cellular RNA and miRNA expression.Keywords
This publication has 101 references indexed in Scilit:
- Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- The role of miRNAs and EBV BARTs in NPCSeminars in Cancer Biology, 2012
- The Epstein–Barr Virus BART microRNAs target the pro-apoptotic protein BimVirology, 2011
- Human tumor virus utilizes exosomes for intercellular communicationProceedings of the National Academy of Sciences of the United States of America, 2010
- Epstein-Barr virus latent membrane protein-2A-induced ΔNp63α expression is associated with impaired epithelial-cell differentiationOncogene, 2010
- Proof for EBV's sustaining role in Burkitt's lymphomasSeminars in Cancer Biology, 2009
- IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3Proceedings of the National Academy of Sciences of the United States of America, 2008
- Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinomaInternational Journal of Cancer, 2008
- Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genesProceedings of the National Academy of Sciences of the United States of America, 2006
- Diet, living conditions and nasopharyngeal carcinoma in tunisia—a case-control studyInternational Journal of Cancer, 1990